A Canadian cannabis retailer disclosed a Form 6-K filing with the SEC on June 15, 2026, marking its latest regulatory submission under the Securities Exchange Act of 1934.

Key Highlights

  • A Canadian cannabis retailer submitted a Form 6-K to the SEC on June 15, 2026, under the Securities Exchange Act of 1934.
  • The filing carries the commission file number 001-40258, assigned to the company’s regulatory disclosures.
  • The document was processed under the SEC’s Washington, D.C. office, identified by the zip code 20549.
  • The filing size was recorded at 61 KB, reflecting standard disclosure requirements for foreign private issuers.

A Canadian cannabis retailer operating in the OTC markets has filed a Form 6-K with the U.S.

Securities and Exchange Commission, reinforcing its compliance with cross-border securities regulations.

The submission, dated June 15, 2026, falls under the Securities Exchange Act of 1934, which governs ongoing reporting obligations for foreign private issuers.

The filing was assigned the commission file number 001-40258, a unique identifier used by the SEC to track corporate disclosures.

This number remains consistent across the company’s regulatory submissions, providing investors with a reference point for historical filings.

The document was processed through the SEC’s Washington, D.C.

office, which oversees enforcement of federal securities laws under the zip code 20549.

The company’s principal executive offices are based in Calgary, Alberta, at 11127 – 15 Street N.E., Unit 112, a location that aligns with its operational footprint in Canada’s legal cannabis sector.

The filing size was 61 KB, a typical range for routine disclosures that do not include extensive financial statements or material events.

Form 6-K filings are mandatory for foreign private issuers when they release material information to their home market regulators or shareholders.

While the document itself does not detail specific financial performance, it signals the company’s adherence to U.S.

securities laws, which may influence investor confidence in its governance practices.

The submission comes as cannabis stocks face heightened scrutiny from regulators and market participants, particularly those trading on over-the-counter exchanges.

The filing’s timing coincides with ongoing discussions about regulatory clarity for cannabis-related businesses in North America.

Investors often monitor such disclosures for updates on corporate actions, leadership changes, or shifts in strategic direction.

The company’s compliance with SEC requirements may also impact its eligibility for inclusion in certain investment funds or indices that prioritize regulatory transparency.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.